Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlternative Liq Regulatory News (ALF)

Share Price Information for Alternative Liq (ALF)

Share Price is delayed by 15 minutes
Get Live Data
0.042    0.0205 (95.35%)
Bid:
0.004
Ask:
0.08
Spread: 0.076 (1,900.00%)
Market Cap: $6.14m
ALF Live PriceLast checked at - London Stock Exchange

Intraday Alternative Liq Share Chart

Shareholder Update

Today 15:00

RNS Number : 4420K
Alternative Liquidity Fund Limited
30 June 2026
 

ALTERNATIVE LIQUIDITY FUND LIMITED

Registered in Guernsey - Number 60552

LEI NUMBER 213800R5CHD76J3LU713

 

Registered Office:

1 Royal Plaza, Royal Avenue,

St Peter Port, Guernsey, GY1 2HL

 

30 June 2026

SHAREHOLDER UPDATE

 

Dear Shareholders

As previously discussed, the Board committed to updating shareholders on the Company's portfolio monetisation strategy and the ensuing plan for the orderly liquidation of the Company.We are pleased to announce that the previously mentioned sale of the Vision FCVS RJ Fund to Vision has now progressed to the final stages of legal completion, and we expect to sign a definitive agreement within the next few weeks. This transaction is expected to trigger a redemption payment from the Vision RJ Cayman Fund to ALF and the other shareholders in the Vision FCVS RJ Fund.

Following completion of that transaction, the Board will seek to sell the Vision Special Credit Opportunities Eletrobras Fund in the secondary market. We anticipate that the process will progress relatively quickly since indicative bids for the asset have already been received.The proceeds from both these transactions will be combined to facilitate a final distribution to shareholders. At that point, the Board intends to convene an Extraordinary General Meeting to seek shareholder approval for the Company to enter voluntary liquidation.The Board expects to provide a further update in the near future once a definitive legal agreement has been signed.

 

Enquiries

 

Tim Gardner, Hindsight Solutions Limited

Tel. +44 7917 630 460

Email: timgardner@hindsightsolutions.co.uk

Website:   https://alternativeliquidityfund.com/

 

 

Apex Fund and Corporate Services (Guernsey) Limited

Telephone: +44 (0) 20 3530 3111

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CIRBXGDLSUXDGLG
Date   Source Headline
15th Jan 20214:35 pmRNSPrice Monitoring Extension
22nd Dec 202011:05 amRNSResult of General Meeting
22nd Dec 202011:00 amRNSResult of AGM
14th Dec 20204:41 pmRNSSecond Price Monitoring Extn
14th Dec 20204:36 pmRNSPrice Monitoring Extension
10th Dec 20208:13 amRNSNet Asset Value and Fact Sheet September 20
9th Dec 20205:06 pmRNSNet Asset Value and Fact Sheet September 20
9th Dec 20204:00 pmRNSNet Asset Value and Fact Sheet September 2020
8th Dec 20203:13 pmRNSNotice of AGM
8th Dec 20203:00 pmRNSCircular and Notice of GM
23rd Nov 20205:00 pmRNSNet Asset Value and Fact Sheet August 2020
29th Oct 20209:41 amRNSAnnual Financial Report
28th Oct 20204:00 pmRNSNet Asset Value and Fact Sheet July 20
28th Oct 202012:59 pmGNWMan Group PLC : Form 8.3 - Alternative Credit Investments plc
23rd Sep 20205:08 pmRNSNet Asset Value and Fact Sheet - 30 June 2020
13th Aug 20203:00 pmRNSInvestment Manager Update
4th Aug 20203:20 pmRNSNet Asset Value and Fact Sheet 29 May 2020
24th Jul 20204:30 pmRNSReturn of Capital
24th Jul 20201:24 pmRNSReturn of Capital
23rd Jun 20203:27 pmRNSNet Asset Value and Fact Sheet - 30 April 2020
11th Jun 202012:07 pmRNSSecond Price Monitoring Extn
11th Jun 202012:02 pmRNSPrice Monitoring Extension
8th Jun 20204:42 pmRNSSecond Price Monitoring Extn
8th Jun 20204:35 pmRNSPrice Monitoring Extension
5th Jun 20204:26 pmRNSNet Asset Value and Fact Sheet - 31 March 2020
29th Apr 20205:00 pmRNSNet Asset Value and Fact Sheet - 28 February 2020
27th Apr 20206:23 pmRNSArticles of Incorporation re LR 9.2.6ER(1)
23rd Apr 20207:10 amRNSNet Asset Value and Fact Sheet 31 January 2020
2nd Apr 20203:14 pmRNSNet Asset Value and Fact Sheet 31 January 2020
25th Mar 20202:30 pmRNSHalf-year Report
21st Feb 20205:00 pmRNSNet Asset Value and Fact Sheet 31 Dec 2019
23rd Jan 20204:00 pmRNSNet Asset Value and Fact Sheet 29 November 2019
9th Jan 20202:10 pmRNSAppointment as Corporate Broker
16th Dec 20195:00 pmRNSNet Asset Value and Fact Sheet October 2019
10th Dec 20195:15 pmRNSNet Asset Value and Fact Sheet 30 September 2019
5th Dec 20194:55 pmRNSReturn of Capital
5th Dec 20194:32 pmRNSResult of AGM
3rd Dec 20195:00 pmRNSNet Asset Value and Fact Sheet 30 August 2019
19th Nov 20195:00 pmRNSNet Asset Value and Fact Sheet 31 July 2019
5th Nov 20193:00 pmRNSResult of EGM
25th Oct 201912:34 pmRNSAnnual Financial Report and Notice of AGM
11th Oct 20195:00 pmRNSPublication of a Prospectus and Circular
2nd Oct 20195:00 pmRNSNet Asset Value and Fact Sheet 28 June 2019
13th Aug 20195:00 pmRNSNet Asset Value and Fact Sheet 31 May 2019
3rd Jul 20195:00 pmRNSNet Asset Value and Fact Sheet 30 April 2019
17th Jun 20192:00 pmRNSNet Asset Value and Fact Sheet 29 March 2019
22nd May 20193:00 pmRNSNet Asset Value and Fact Sheet 28 February 2019
20th May 20194:41 pmRNSSecond Price Monitoring Extn
20th May 20194:35 pmRNSPrice Monitoring Extension
16th Apr 20195:00 pmRNSNet Asset Value and Fact Sheet 31 Jan 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.